These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 1984696

  • 1. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL.
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [Abstract] [Full Text] [Related]

  • 2. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 3. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL.
    J Clin Psychopharmacol; 1992 Feb; 12(1):11-8. PubMed ID: 1552034
    [Abstract] [Full Text] [Related]

  • 4. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R.
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [Abstract] [Full Text] [Related]

  • 5. Serotonin and effect sizes of antiobsessive agents.
    Pato MT, Gluhoski V.
    Am J Psychiatry; 1992 Mar; 149(3):420-1. PubMed ID: 1531582
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An open trial of buspirone in obsessive-compulsive disorder.
    Jenike MA, Baer L.
    Am J Psychiatry; 1988 Oct; 145(10):1285-6. PubMed ID: 3048120
    [Abstract] [Full Text] [Related]

  • 8. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL.
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH.
    Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
    [Abstract] [Full Text] [Related]

  • 12. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB.
    Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA.
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.